These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diagnostic value of dilated intercellular space and histopathologic scores in gastroesophageal reflux disease. Cui R; Zhang H; Zhou L; Lu J; Xue Y; Wang Y; Yan X; Lin L; Lin S Dis Esophagus; 2015; 28(6):530-7. PubMed ID: 25130660 [TBL] [Abstract][Full Text] [Related]
6. Refractory Heartburn: A Challenging Problem in Clinical Practice. Domingues G; Moraes-Filho JPP; Fass R Dig Dis Sci; 2018 Mar; 63(3):577-582. PubMed ID: 29352757 [TBL] [Abstract][Full Text] [Related]
7. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease. Pace F; Pace M Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016 [TBL] [Abstract][Full Text] [Related]
8. Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy. Ang D; How CH; Ang TL Singapore Med J; 2016 Oct; 57(10):546-551. PubMed ID: 27779277 [TBL] [Abstract][Full Text] [Related]
12. [Noncardiac chest pain and gastroesophageal reflux disease]. Dimache M; Turcan E; Nătase M Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):342-8. PubMed ID: 20700964 [TBL] [Abstract][Full Text] [Related]
13. Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett's esophagus. Baldaque-Silva F; Vieth M; Debel M; Håkanson B; Thorell A; Lunet N; Song H; Mascarenhas-Saraiva M; Pereira G; Lundell L; Marschall HU World J Gastroenterol; 2017 May; 23(17):3174-3183. PubMed ID: 28533674 [TBL] [Abstract][Full Text] [Related]
14. Patients with refractory reflux symptoms often do not have GERD. Herregods TV; Troelstra M; Weijenborg PW; Bredenoord AJ; Smout AJ Neurogastroenterol Motil; 2015 Sep; 27(9):1267-73. PubMed ID: 26088946 [TBL] [Abstract][Full Text] [Related]
15. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives. Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of salivary pepsin for gastroesophageal reflux disease. Yadlapati R; Kaizer A; Greytak M; Ezekewe E; Simon V; Wani S Dis Esophagus; 2021 Apr; 34(4):. PubMed ID: 33180095 [TBL] [Abstract][Full Text] [Related]
17. The proton pump inhibitor (PPI) test in GERD: does it still have a role? Gasiorowska A; Fass R J Clin Gastroenterol; 2008 Sep; 42(8):867-74. PubMed ID: 18645525 [TBL] [Abstract][Full Text] [Related]
18. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease. Saritas Yuksel E; Hong SK; Strugala V; Slaughter JC; Goutte M; Garrett CG; Dettmar PW; Vaezi MF Laryngoscope; 2012 Jun; 122(6):1312-6. PubMed ID: 22447277 [TBL] [Abstract][Full Text] [Related]
19. Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain. Lemire S Can J Gastroenterol; 1997 Sep; 11 Suppl B():37B-40B. PubMed ID: 9347176 [TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain]. Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]